References
- Budzikiewicz H., Djerassi C., Williams D. H. Mass Spectrometry of Organic Compounds. Holden-Day, San Francisco 1967; 468–471
- Carrington R., Frigerio A. Mass fragmentation in drug research. Drug Metabolism Reviews 1977; 6: 243–282
- Cassidy S., Henry J. Fatal toxicity of antidepressant drugs in overdose. British Medical Journal 1987; 295: 1021–1024
- Coutts R. T., Hussain M. S., Micetich R. G., Baker G. B., Daneshtalab M. The metabolism of trimipramine in the rat. Biomedical and Environmental Mass Spectrometry 1990; 19: 793–806
- Coutts R. T., Jones G. R. Significance of analytical techniques in drug metabolism studies. Concepts in Drug Metabolism, P. Jenner, B. Testa. Marcel Dekker, New York 1980; 1–51, Part A
- Crammer J. L., Scott B., Rolfe B. Metabolism of 14C-imipramine: II. Urinary metabolites in man. Psychopharmacologia (Berlin) 1969; 15: 207–225
- Edwards D. J., Sorisio D. A., Sedlock M. L. Decreases in tyrosine and p-hydroxyphenylglycol caused by various antidepressants. Biochemical Pharmacology 1988; 37: 2069–2075
- Freeman J. J., Sulser F. Iprindole-amphetamine interactions in the rat: the role of aromatic hydroxylation of amphetamine in its mode of action. Journal of Pharmacology and Experimental Therapeutics 1972; 183: 307–315
- Gluckman M. I., Baum T. The pharmacology of iprindole, a new antidepressant. Psychopharmacologia (Berlin) 1969; 15: 169–185
- Green A. L., O'Grady J. E., Vass M. The effect of some tricyclic antidepressants on the inhibition of mouse brain monoamine oxidase in vivo by phenelzine. Journal of Pharmacy and Pharmacology 1988; 41: 50–51
- Hegadoren K. M., Baker G. B., Coutts R. T., Dewhurst W. G. Interactions of iprindole with fenfluramine metabolism in rat brain and liver. Journal of Psychiatry and Neuroscience 1991; 11
- Lahti R. A., Maickel R. P. The tricyclic antidepressants-inhibition of norepinephrine uptake as related to potentiation of norepinephrine and clinical efficacy. Biochemical Pharmacology 1971; 20: 482–486
- Li P. P., Warsh J. J., Stanacev N. Z. In vitro and ex vivo effects of antidepressants on rat brain membrane-bound phosphatidylinositol synthetase activity. Neurochemistry Research 1988; 13: 789–795
- Midha K. K., Hubbard J. W., Bailey K., McGilveray I. J. The identification of two new urinary metabolites of fenfluramine in man. Xenobiotica 1983; 13: 31–38
- Miller K. W., Freeman J. J., Dingell J. V., Sulser F. On the mechanism of amphetamine potentiation by iprindole. Experientia (Basel) 1970; 26: 281–291
- Rudorfer M. V., Potter W. Z. Metabolism of drugs used in affective disorders. Pharmacotherapy of Affective Disorders: Theory and Practice, W. G. Dewhurst, G. B. Baker. New York University Press, New York 1985; 382–448
- Sedlock M. L., Ravitch J., Edwards D. J. The effect of imipramine and iprindole on the metabolism of octopamine in the rat. Neuropharmacology 1985; 24: 705–708
- Sisenwine S. F., Tio C. O., Ruelius H. W. The disposition of [14C]iprindole in man, dog, miniature swine, rhesus monkey and rat. Xenobiotica 1979; 9: 237–246